|
Market Closed -
London S.E.
09:30:00 01/05/2025 +03
|
5-day change | 1st Jan Change | ||
| 0.2250 GBX | -.--% |
|
+2.27% | - |
| 03-02 | Kanabo Group PLC Announces Termination Of Director Appointment of Sharon Malka, Effective February 27, 2026 | CI |
| 12-12 | Quantum Helium increases Sagebrush project interest | AN |
| Market Cap | 5.38M 7.12M 6.25M 5.9M 10.06M 682M 10.13M 70.59M 27.34M 349M 26.72M 26.15M 1.12B | P/E 2022 |
-1.15x | P/E 2023 | -1.88x |
|---|---|---|---|---|---|
| Enterprise Value | 2.44M 3.23M 2.83M 2.67M 4.56M 309M 4.6M 32.01M 12.4M 158M 12.12M 11.86M 508M | EV / Sales 2022 |
8.33x | EV / Sales 2023 | 16.5x |
| Free-Float |
93.73% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 week | +2.27% | ||
| Current month | +2.27% | ||
| 1 month | +2.27% | ||
| 3 months | +2.27% |
| Current year | 0.22 |  | 0.22 |
| 1 year | 0.22 | | 0.22 |
| 3 years | 0.15 | | 3.2 |
| 5 years | 0.15 | | 17.5 |
| 10 years | 0.15 | | 51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Avihu Tamir
CEO | Chief Executive Officer | 45 | 28/06/2021 |
Ophir Shimshi
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Avihu Tamir
BRD | Director/Board Member | 45 | 28/06/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/31/24 A | Others | Chairman | 18,011,111 | 2.8479% | ||
| 10/29/24 A | Free | Chairman | 17,361,111 | 2.7452% | ||
| 8/28/24 A | Buy | Chief Technology Officer | 75,187 | 0.0119% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +2.27% | -.--% | -87.14% | 1.84M | |
| +0.13% | +2.65% | +65.61% | +114.28% | 1,055B | |
| +0.20% | +0.46% | +52.60% | +69.24% | 654B | |
| -0.29% | +0.14% | +20.96% | +70.93% | 467B | |
| -0.85% | +0.98% | +41.29% | +44.38% | 348B | |
| +0.71% | +4.08% | +22.24% | +29.51% | 275B | |
| +1.23% | +0.42% | +14.57% | +12.13% | 258B | |
| +2.11% | +7.51% | +52.89% | +55.37% | 224B | |
| +0.83% | +0.55% | +35.99% | +101.70% | 187B | |
| 0.00% | -10.14% | -29.94% | -60.30% | 171B | |
| Average | +0.32% | -0.34% | +27.62% | +35.01% | 363.84B | |
| Weighted average by Cap. | +0.02% | +1.32% | +41.54% | +67.83% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 603K 798K 701K 662K 1.13M 76.52M 1.14M 7.92M 3.07M 39.09M 3M 2.93M 126M | 895K 1.19M 1.04M 982K 1.68M 114M 1.69M 11.75M 4.55M 58.02M 4.45M 4.35M 186M |
| Net income | -6.87M -9.09M -7.98M -7.54M -12.85M -871M -12.95M -90.17M -34.93M -445M -34.14M -33.4M -1.43B | -7.99M -10.58M -9.28M -8.76M -14.95M -1.01B -15.06M -105M -40.62M -518M -39.71M -38.85M -1.66B |
| Net Debt | -3.01M -3.99M -3.5M -3.31M -5.64M -382M -5.68M -39.55M -15.32M -195M -14.97M -14.65M -628M | -2.94M -3.89M -3.41M -3.22M -5.5M -373M -5.54M -38.58M -14.94M -190M -14.61M -14.29M -612M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- KNB Stock
Select your edition
All financial news and data tailored to specific country editions
